Results 1 - 25 from 45 for "farmaceutica remedia"
-
Farmaceutica Remedia H1/2024 Turnover Rises 24% To RON355M; Profit Down To RON33,000
08.30.2024
Farmaceutica Remedia, a major player on the drug wholesale market, registered RON355.2 million revenues in the first half of 2024, 24% above the H1/2023 level. more
-
Farmaceutica Remedia Budgets RON14M for Investments in 2024
08.23.2024
Farmaceutica Remedia, a major player on the local drug wholesale market, has earmarked total investments of over RON14 million for 2024. more
-
Farmaceutica Remedia Seeks To Raise Credit Facility From Banca Transilvania To RON100M
07.17.2024
Farmaceutica Remedia (RMAH.RO), one of the largest businesses in the local pharmaceutical market, is calling shareholders to vote on raising the cap of the credit facility from Banca Transilvania. more
-
Farmaceutica Remedia Reports 27% Higher Turnover, Of RON172.6M, For Q1/2024
05.14.2024
Farmaceutica Remedia Group (RMAH.RO), with activities in drug wholesale for pharmacies, but also for clinics and private hospitals, in pharma retail and sale of robots for pharmacies, reported a more
-
Farmaceutica Remedia Seeks To Distribute RON4.7M Dividends, With 7.2% Yield
03.21.2024
Farmaceutica Remedia Group, with activities in drug wholesale for pharmacies, but also for clinics and private hospitals, in pharma retail and sale of robots for pharmacies, is considering more
-
Farmaceutica Remedia's Profit Surges 19.7% YoY To RON7.2M In 2023
02.28.2024
Farmaceutica Remedia Group, with activities in drug wholesale for pharmacies, but also for clinics and private hospitals, in pharma retail and sale of robots for pharmacies, ended 2023 with a turnover more
-
Farmaceutica Remedia Hits RON6M Profit, Up 24.2% in Jan-Sept 2023
11.14.2023
Farmaceutica Remedia Group, with activities in drug wholesale for pharmacies, but also for clinics and private hospitals, in pharma retail and sale of robots for pharmacies, ended the first nine more
-
Farmaceutica Remedia Ends H1/2023 With RON282.4M Turnover, Up 9% YoY
08.17.2023
Farmaceutica Remedia Group, with activities in drug wholesale for pharmacies, but also for clinics and private hospitals, in pharma retail and sale of robots for pharmacies, ended the first half of more
-
Farmaceutica Remedia 1Q/2023 Turnover Up 10% To RON136M
05.18.2023
Remedia group, with activities in drug wholesale for pharmacies, but also for clinics and private hospitals, in pharma retail and sale of robots for pharmacies, reported RON136 million turnover in the more
-
Farmaceutica Remedia Nears RON400M Turnover in Jan-Sept 2022, Up 13% from Year-Earlier Period
12.08.2022
Remedia group, with activities in drug wholesale for pharmacies, but also for clinics and private hospitals, in pharma retail and sale of robots for pharmacies, posted RON390 million turnover in the more
-
Farmaceutica Remedia Set to Cut Personnel Fluctuation with Aid of Nine Robots
11.04.2022
Farmaceutica Remedia in 2021 bet on a new market niche, installing robots in pharmacy warehouses, and nine pharmacies already have this system installed at present. The price starts from EUR70,000 and more
-
Farmaceutica Remedia Net Profit Grows 15-Fold YoY To RON38M In 2020
02.17.2021
Pharmaceutical distributor Farmaceutica Remedia Deva (RMAH.RO) said Wednesday it ended 2020 with a turnover of RON442 million, down 1% on the year, and a net profit of RON38 million, 15-fold higher more
-
Farmaceutica Remedia Buys Back 10% Of Its Own Shares In RON6.4M Deals
01.13.2021
Pharmaceutical distributor Farmaceutica Remedia Deva (RMAH.RO) said Wednesday in a stock market report that Valentin Norbert Tarus, the company’s CEO and majority shareholder, and SC Tarus Media more
-
Farmaceutica Remedia Seeks to Buy Back 10% of Share Capital for RON6.4M
09.09.2020
Farmaceutica Remedia (RMAH.RO) summoned shareholders for October 14 to approve a plan to buy back maximum 10% of the company's own share capital in view of a share capital reduction. more
-
Farmaceutica Remedia Owner Raises Stake to 80.5% in RON7.16M Transaction
02.20.2020
The majority shareholder of Farmaceutica Remedia (RMAH.RO) Valentin-Norbert Tarus, who is also the company's board chairman and general manager, has acquired 15,9 million shares in the company for more
-
Phoenix Group, Owner Of Help Net Pharmacy Chain, Acquires 52 Remedia Drugstores For EUR8.5M
02.12.2020
Farmaceutica Remedia (RMAH.RO), which operates a 100-drugstore chain, has announced the sale of 52 pharmacies to Help Net, held by Germany’s Phoenix Group, within a transaction of up to EUR8.5 more
-
Remedia Pharmacy Chain Up For Sale For At Least EUR5M
12.05.2019
-
Farmaceutica Remedia Shares Surge After Sale Plan Announcement
10.29.2019
Shares of Farmaceutica Remedia Deva (RMAH.RO), which operates a 100-pharmacy chain, gained 15% on the Bucharest Stock Exchange Tuesday after the wholesaler announced it was looking to sell its entire more
-
Farmaceutica Remedia 2018 Consolidated Sales Up 32% On Year To RON463M
02.22.2019
-
Farmaceutica Remedia Turnover Surges 47% To RON158M In 1H/2017
08.09.2017
-
Farmaceutica Remedia Profit Surges 48.6% To RON75M In 1Q/2017
05.16.2017
-
Farmaceutica Remedia Posts RON107M Turnover In January-June
08.10.2016
Pharmaceutical distributor Farmaceutica Remedia Deva (RMAH.RO) registered a turnover of RON107.08 million in January-June 2016, down 6.25% from the year-earlier period. more
-
Farmaceutica Remedia Proposes Dividends Of RON1.6M, Same As Last Year
03.12.2015
Pharmaceutical distributor Farmaceutica Remedia Deva (RMAH.RO) proposes dividends of RON1.59 million (EUR357,800) from its 2014 profit, the same as distributed earnings for 2013. more
-
Farmaceutica Remedia Sales Grew 4.3% In 2014, To RON244.7M
02.11.2015
Pharmaceutical wholesaler Farmaceutica Remedia Deva (RMAH.RO) had net sales of RON244.68 million (EUR55 million) in 2014, up 4.3% on the year, and its net profit rose 3.6%, to RON3.12 million more
-
Farmaceutica Remedia Sales Stagnated In First Nine Months, Profit Up 58%
10.30.2014
Pharmaceutical distributor Farmaceutica Remedia Deva (RMAH.RO) reported net sales of RON175.56 million (EUR39.47 million) in the first nine months of the year, up 0.7%, and its net profit rose 58%, to more